Moreover, computational analyses of drug response data in a large cancer cell line panel [42] further supports that high DET1 or COP1 expression is correlated with low IC50 values (i.e., sensitivity) for five different MEK inhibitors across a colorectal cancer cell line panel (Fig. 3g). The gene discussed is DET1; the disease is cancer.